Nina Moiseiwitsch

Moiseiwitsch, N., Nellenbach, K. A., Downey, L. A., Boorman, D., Brown, A. C., & Guzzetta, N. A. (2023). Influence of Fibrinogen Concentrate on Neonatal Clot Structure When Administered Ex Vivo After Cardiopulmonary Bypass. ANESTHESIA AND ANALGESIA, 137(3), 682–690. https://doi.org/10.1213/ANE.0000000000006357

Moiseiwitsch, N., Zwennes, N., Szlam, F., Sniecinski, R., & Brown, A. (2022, October 5). COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. https://doi.org/10.1111/jth.15882

Moiseiwitsch, N., Nellenbach, K. A., Guzzetta, N. A., Brown, A. C., & Downey, L. (2021, November 23). Ex Vivo and In Vivo Evaluation of Fibrinogen Concentrate to Mitigate Post-Surgical Bleeding in Neonates. BLOOD, Vol. 138. https://doi.org/10.1182/blood-2021-153823

Mihalko, E. P., Nellenbach, K., Krishnakumar, M., Moiseiwitsch, N., Sollinger, J., Cooley, B. C., & Brown, A. C. (2021, December 11). Fibrin-specific poly(N-isopropylacrylamide) nanogels for targeted delivery of tissue-type plasminogen activator to treat thrombotic complications are well tolerated in vivo. BIOENGINEERING & TRANSLATIONAL MEDICINE. https://doi.org/10.1002/btm2.10277

Moiseiwitsch, N., & Brown, A. C. (2021). [Review of Neonatal coagulopathies: A review of established and emerging treatments]. EXPERIMENTAL BIOLOGY AND MEDICINE, 246(12), 1447–1457. https://doi.org/10.1177/15353702211006046